UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

T32 Training Program

The University of Nebraska Medical Center administers a NIH sponsored neuroimmunology of disease T32 training program. This highly selective program, which accepts around four students per year, provides research opportunities with mentors in various aspects of study, including:

  • Investigating the role played by glial inflammatory activities in brain disease
  • Utilizing advanced functional and structural neuroimaging to understand normal and aberrant cognitive processes
  • Cell signaling in the neuroimmunomodulation by drugs of abuse
  • Studying pathogenesis and immune responses elicited by Staphylococcus aureus
  • Investigating macrophage production of neurotoxic products that follow viral-infection and immune activation
  • Using non-human primate modeling of central nervous system infections
  • Using experimental paradigms to decipher the mechanisms mediating in the blood-brain barrier
  • Develop novel therapeutic strategies that may enhance neuronal function and survival in neurodegenerative diseases
  • Develop small animal models to study the pathogenesis of human-specific viral co-infection
  • Target cell types of the immune system to fight against HIV

Students in the training program receive additional training workshops in research rigor and reproducibility, attend several clinical rotations related to their area of research, are provided with a biostatistician as a consultant for the analysis of their research, and complete a “Cross-Disciplinary Internship” – a 3 to 4 month project completed in another laboratory that brings a new research approach or methodology to their dissertation research project.

In addition to waived tuition and health insurance/fees being covered, students in the training program receive additional support for conference travel and research supplies for their research project. To receive an application, send a note to Dr. Dan Monaghan (dtmonagh@unmc.edu). Completed applications are due June 1st.